Arlington Partners LLC Amgen Inc Transaction History

Arlington Partners LLC

$241 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	SELL	$214.27 - $253.37 $18,427 - $21,789	-86 Reduced 2.31%	3,631 $806,000
Q1 2023 Apr 26, 2023	BUY	$225.79 - $275.2 $209,081 - $254,835	926 Added 33.18%	3,717 $898,000
Q4 2022 Jan 19, 2023	BUY	$229.03 - $291.01 $34,125 - $43,360	149 Added 5.64%	2,791 $733,000
Q3 2022 Oct 28, 2022	BUY	$224.46 - $253.15 $8,753 - $9,872	39 Added 1.5%	2,642 $596,000
Q2 2022 Jul 25, 2022	SELL	$230.71 - $256.74 $22,609 - $25,160	-98 Reduced 3.63%	2,603 $633,000
Q1 2022 Apr 14, 2022	SELL	$219.27 - $242.57 $136,385 - $150,878	-622 Reduced 18.72%	2,701 $653,000
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $38,383 - $43,926	193 Added 6.17%	3,323 $748,000
Q3 2021 Oct 15, 2021	BUY	$212.27 - $248.7 $321,589 - $376,780	1,515 Added 93.81%	3,130 $666,000
Q2 2021 Jul 07, 2021	BUY	$233.58 - $259.14 $29,431 - $32,651	126 Added 8.46%	1,615 $394,000
Q1 2021 Apr 19, 2021	SELL	$221.91 - $258.6 $33,730 - $39,307	-152 Reduced 9.26%	1,489 $370,000
Q4 2020 Jan 13, 2021	BUY	$216.38 - $257.67 $21,205 - $25,251	98 Added 6.35%	1,641 $377,000
Q2 2020 Jul 13, 2020	BUY	$197.81 - $242.74 $111,762 - $137,148	565 Added 57.77%	1,543 $364,000
Q1 2020 Apr 13, 2020	BUY	$182.24 - $241.7 $88,933 - $117,949	488 Added 99.59%	978 $198,000
Q4 2019 Jan 16, 2020	BUY	$189.21 - $243.2 $18,921 - $24,320	100 Added 25.64%	490 $118,000
Q3 2019 Oct 18, 2019	SELL	$174.11 - $208.62 $230,695 - $276,421	-1,325 Reduced 77.26%	390 $75,000
Q2 2019 Jul 10, 2019	BUY	$166.7 - $195.41 $262,552 - $307,770	1,575 Added 1125.0%	1,715 $316,000
Q4 2018 Jan 10, 2019	BUY	$178.4 - $208.25 $11,596 - $13,536	65 Added 86.67%	140 $27,000
Q3 2018 Oct 23, 2018	BUY	$185.29 - $208.89 $13,896 - $15,666	75 New	75 $16,000
Q2 2018 Jul 11, 2018	SELL	$166.05 - $186.51 $12,453 - $13,988	-75 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$169.43 - $198.0 $12,707 - $14,850	75 New	75 $13,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Partners LLC with notifications on news.

Account